GSA Capital Partners LLP Invests $92,000 in Teladoc Health, Inc. (NYSE:TDOC)

GSA Capital Partners LLP purchased a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,016 shares of the health services provider’s stock, valued at approximately $92,000.

Other hedge funds have also made changes to their positions in the company. Signaturefd LLC boosted its stake in shares of Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after buying an additional 1,715 shares during the period. International Assets Investment Management LLC acquired a new position in Teladoc Health during the 2nd quarter worth approximately $29,000. Blue Trust Inc. raised its holdings in shares of Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares in the last quarter. Doheny Asset Management CA acquired a new stake in Teladoc Health in the second quarter valued at $46,000. Finally, Benjamin F. Edwards & Company Inc. lifted its position in shares of Teladoc Health by 209.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after buying an additional 3,396 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on TDOC shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $10.00 target price on shares of Teladoc Health in a report on Tuesday, August 20th. Evercore ISI boosted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. The Goldman Sachs Group started coverage on shares of Teladoc Health in a research report on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective for the company. Oppenheimer reduced their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $12.08.

Insider Buying and Selling

In related news, CFO Mala Murthy sold 8,750 shares of Teladoc Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the transaction, the chief financial officer now directly owns 85,767 shares of the company’s stock, valued at $614,091.72. The trade was a 9.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Michael Willem Waters sold 4,218 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $30,200.88. Following the completion of the transaction, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. This trade represents a 5.11 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 20,051 shares of company stock valued at $143,565 in the last quarter. Company insiders own 0.95% of the company’s stock.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $12.02 on Tuesday. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of -2.08 and a beta of 0.90. The company’s 50-day simple moving average is $9.18 and its 200-day simple moving average is $9.25. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a one year low of $6.76 and a one year high of $22.54.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Equities analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.